The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

Item
http://www.wikidata.org/entity/Q34266810
The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populationsBias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersHigh penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.Towards evidence-based management of inherited breast and breast-ovarian cancer.Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models.Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.Breast cancer susceptibility testing: past, present and future.No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriers.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway.Genetic factors influencing prostate cancer risk in Norwegian men.Mutations in context: implications of BRCA testing in diverse populations.
P2860

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

Item
http://www.wikidata.org/entity/Q34266810
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@ast
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@en
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@nl
type
label
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@ast
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@en
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@nl
prefLabel
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@ast
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@en
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The Norwegian founder mutation ...... in the risk of ovarian cancer.
@en
P2093
P304
P31
P356
10.1016/S0959-8049(03)00548-3
P433
P478
P50
P577
P698
P921